Zhou et al. (2018) revealed that overexpression of miR-132-3p can enhance the chondrogenic differentiation of rat MSCs by targeting ADAMTS-5, indicating that miR-132-3p may be a new therapeutic for patients with osteoarthritis. Here, ADAMTS5 is linked to osteoarthritis.